Skip to main content

Table 3 The mRNA expression of β2M, HER2, HIF-1α, VEGF and Bcl-2 in two types of breast cancer tissues

From: β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER breast cancer with HER2

 

Luminal A (n = 29)

Basal-like (n = 9)

Fold-change median (range)

Z

p

Fold-change median (range)

Z

p

β2M

0.9202 (0.18–7.29)

− 0.622

0.534

0.6395 (0.25–2.32)

− 0.652

0.515

HER2

1.0755 (0.20–5.00)

−1.314

0.189

0.7955 (0.01–8.31)

− 0.889

0.374

HIF-1α

1.0281 (0.05–6.43)

−0.400

0.689

0.7346 (0.21–2.34)

−0.652

0.515

VEGF

0.9526 (0.19–7.86)

−0.119

0.905

1.0070 (0.02–3.59)

−0.296

0.767

Bcl-2

1.1154 (0.11–9.61)

−1.571

0.116

0.3015 (0.04–3.10)

−0.652

0.515

  1. n The number of patients with breast cancer